<DOC>
	<DOC>NCT01889251</DOC>
	<brief_summary>The purpose of this study is to evaluate the superiority regarding vitreomacular adhesion (VMA) resolution of a single intravitreal injection of A01016 (Ocriplasmin) compared to sham-injection in subjects with symptomatic VMA.</brief_summary>
	<brief_title>A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion</brief_title>
	<detailed_description />
	<mesh_term>Tissue Adhesions</mesh_term>
	<criteria>Symptomatic vitreomacular adhesion (VMA) which, in the opinion of the Investigator, is related to decreased visual function; Best corrected visual acuity (BCVA) of 20/25 or worse in the study eye; BCVA of 20/800 or better in the nonstudy eye; Provide written informed consent; Follow specified instructions during study period; Other protocoldefined inclusion criteria may apply. Evidence of proliferative retinopathy, exudative agerelated macular degeneration, or retinal vein occlusion in the study eye; Vitreous hemorrhage or other opacification; High myopia in the study eye; Ocular surgery, laser photocoagulation treatment, or intravitreal injection(s) in the study eye in the prior 3 months; Uncontrolled glaucoma in the study eye; History of retinal detachment in either eye; Active infection in either eye; Pregnant or of childbearing potential and not utilizing acceptable form of contraception; Participation in another investigational drug study within 30 days prior to this study; Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Vitreomacular Adhesion</keyword>
	<keyword>Vitreomacular Traction</keyword>
	<keyword>Vitreomacular Traction Syndrome</keyword>
	<keyword>Vitrectomy</keyword>
	<keyword>Central Visual Field Defect</keyword>
	<keyword>Blind Spot</keyword>
	<keyword>Intravitreal Injection</keyword>
	<keyword>Macula</keyword>
	<keyword>Retina</keyword>
	<keyword>Decreased Visual Acuity</keyword>
	<keyword>Visual Complaint</keyword>
	<keyword>SD-OCT</keyword>
	<keyword>Macular Hole</keyword>
</DOC>